Abstract: Technologies are generally provided for a trans-urethral sling delivery device for deploying a sub-urethral sling to support a urethra to treat urinary incontinence. The delivery device may include a conical-shaped cap attached to a distal end of the sling, the cap configured to puncture the urethra to provide access to an area surrounding the urethra. The sling may be wrapped in a reduced profile around a delivery tool having flexible spreading members extending away from each other at an end of the delivery tool. The spreading members may be inserted within the cap, and the device may be inserted through the urethra to deploy the sling. The delivery tool may be gradually removed from urethra, removing the spreading members from the cap, such that the spreading members may expand to spread the sling to a flattened configuration as the spreading members are moved along a length of the sling.

Abstract: A valvuloplasty system comprises a balloon adapted to be placed adjacent leaflets of a valve. The balloon is inflatable with a liquid. The system further includes a shock wave generator within the balloon that produces shock waves. The shock waves propagate through the liquid and impinge upon the valve to decalcify and open the valve.

Abstract: Devices and methods are disclosed herein for preventing or treating ventilator associated pneumonia in a mammalian subject. The device includes an endotracheal tube having an interior surface and an exterior surface; and one or more closed cell layers in contact with the exterior surface and circumferentially surrounding one or more longitudinal portion of the endotracheal tube, wherein the closed cell layer is flexibly shaped to reversibly form a seal in a trachea of a mammalian subject.

Abstract: Computational systems and methods for reporting information regarding appurtenances to wound dressings are described. A system can include an appurtenance to a wound dressing, including a substrate, a transmission unit, a selectively activated switch, and a projection of a size and shape to extend into an interior region of a wound dressing and configured to sample a fluid associated with a wound; a local unit, including a receiver configured to receive signals from the transmission unit, a transmitter configured to send signals to the transmission unit, a processor, non-volatile memory, and a power source; and a central assembly, including a processor, a receiver configured to receive signals from the local unit, and at least one user interface.

Abstract: Systems and methods for wearable injection guides are described, which include: acquiring one or more digital images of a body region of an individual with at least one image capture device; creating a digitally rendered model of a wearable injection guide from the one or more digital images of the body region of the individual; adding one or more digitally rendered fiducials indicative of at least one treatment parameter to the digitally rendered model of the wearable injection guide; and forming the wearable injection guide from the digitally rendered model of the wearable injection guide, the formed wearable injection guide including one or more fiducials corresponding to the one or more digitally rendered fiducials on the digitally rendered model of the wearable injection guide.

Abstract: A valvuloplasty system comprises a balloon adapted to be placed adjacent leaflets of a valve. The balloon is inflatable with a liquid. The system further includes a shock wave generator within the balloon that produces shock waves. The shock waves propagate through the liquid and impinge upon the valve to decalcify and open the valve.

Abstract: Systems and methods for wearable injection guides are described, which include: acquiring one or more digital images of a body region of an individual with at least one image capture device; creating a digitally rendered model of a wearable injection guide from the one or more digital images of the body region of the individual; adding one or more digitally rendered fiducials indicative of at least one treatment parameter to the digitally rendered model of the wearable injection guide; and forming the wearable injection guide from the digitally rendered model of the wearable injection guide, the formed wearable injection guide including one or more fiducials corresponding to the one or more digitally rendered fiducials on the digitally rendered model of the wearable injection guide.

Abstract: Prosthetic artificial joints are described, including hip, knee and shoulder joints.

Abstract: Prosthetic artificial joints are described, including hip, knee and shoulder joints. In some embodiments, a artificial joint prosthesis includes: a bone-facing surface of a artificial joint prosthesis, the bone-facing surface configured to face a bone-prosthesis interface in vivo; a non-contact surface of the artificial joint prosthesis, the non-contact surface adjacent to the bone-facing surface of the artificial joint prosthesis; at least one fluid deflection structure positioned adjacent to the non-contact surface, the fluid deflection structure positioned to deflect synovial fluid away from the bone-prosthesis interface in vivo; and a mechanism attached to the fluid deflection structure, the mechanism operable to move the fluid deflection structure to direct synovial fluid away from the bone-prosthesis interface in vivo.

Abstract: Artificial joint prosthetic components including synovial fluid deflection structures are described. Embodiments of artificial joint prosthesis include those with: a bone-facing surface of a artificial joint prosthesis, the bone-facing surface configured to face a bone-prosthesis interface in vivo; a non-contact surface of the artificial joint prosthesis; and at least one fluid deflection structure positioned on the non-contact surface, the fluid deflection structure positioned to deflect synovial fluid away from the bone-prosthesis interface in vivo.

Abstract: Artificial joint prostheses, including hip, knee and shoulder joints, are described. In some aspects, an artificial joint prosthesis includes: a bone-facing surface of an artificial joint prosthesis, the bone-facing surface configured to face a bone-prosthesis interface in vivo; a non-contact surface of the artificial joint prosthesis, the non-contact surface adjacent to the bone-facing surface of the artificial joint prosthesis; at least one fluid deflection structure attached to the non-contact surface, the fluid deflection structure positioned to direct a flow of synovial fluid away from the bone-prosthesis interface in vivo; and at least one particle retaining structure positioned to contact the directed flow of synovial fluid and configured to retain particles present within the synovial fluid.

Abstract: Systems and methods for wearable injection guides are described, which include: acquiring one or more digital images of a body region of an individual with at least one image capture device; creating a digitally rendered model of a wearable injection guide from the one or more digital images of the body region of the individual; adding one or more digitally rendered fiducials indicative of at least one treatment parameter to the digitally rendered model of the wearable injection guide; and forming the wearable injection guide from the digitally rendered model of the wearable injection guide, the formed wearable injection guide including one or more fiducials corresponding to the one or more digitally rendered fiducials on the digitally rendered model of the wearable injection guide.

Abstract: Methods and systems are described for unobtrusively monitoring patient activity to determine compliance of the patient with a prescribed regimen for treating for a brain-related disorder. Patient activity associated with routine patient activities is detected with an activity sensor at the patient location, and activity data is transmitted to a monitoring location. Patient activity is processed at the patient location and/or monitoring location to identify activity parameters and/or patterns that indicate whether the patient has complied with the prescribed treatment regimen. Patient identity may be determined through biometric identification or other authentication techniques. The system may provide a report to an interested party, for example a medical care provider or insurance company, regarding compliance of the patient with the prescribed treatment regimen.

Abstract: Methods and systems for monitoring compliance of a patient with a prescribed treatment regimen are described. Two or more patient activities (including e.g., speech activity) are analyzed to determine compliance with a treatment for a brain-related disorder. Activity is detected unobtrusively during performance of routine activities with activity sensor(s) at the patient location, patient speech is detected during use of a communication system such as a mobile telephone, and activity data is sent to a monitoring system at a monitoring location. Activity and/or speech data is processed at the patient location or monitoring location to identify activity parameters or patterns that indicate whether the patient has complied with the treatment regimen. Patient identity may be determined through biometric identification or other authentication techniques. The system may provide a report to an interested party, for example a medical care provider or insurance company, regarding patient compliance.

Abstract: Methods and systems are described for monitoring patient speech to determine compliance of the patient with a prescribed regimen for treating for a brain-related disorder. Patient speech is detected with an audio sensor at the patient location, and speech data is transmitted to a monitoring location. Patient speech is processed at the patient location and/or monitoring location to identify speech parameters and/or patterns that indicate whether the patient has complied with the prescribed treatment regimen. Patient identity may be determined through biometric identification or other authentication techniques. The system may provide a report to an interested party, for example a medical care provider, based on whether (and/or the extent to which) the patient has complied with the prescribed treatment regimen. The monitoring system may transmit a report to a wireless device such as a pager or cell phone, generate an alarm or notification, and/or store information for later use.

Abstract: Methods and systems are described for unobtrusively monitoring patient activity to determine compliance of the patient with a prescribed regimen for treating a brain-related disorder. Patient activity associated with routine activities is detected with an activity sensor at the patient location, and activity data is transmitted to a monitoring location. The activity sensor and other components at the patient location may be incorporated into, or associated with, a cell phone, computing system, game system, appliance, or vehicle system, for example. Patient activity is processed at the patient location and/or monitoring location to identify activity parameters and/or patterns that indicate whether the patient has complied with the prescribed treatment regimen. Patient identity may be determined through biometric identification or other authentication techniques.

Abstract: Methods and systems are described for monitoring patient speech to determine compliance of the patient with a prescribed regimen for treating for a brain-related disorder. Patient speech is detected with an audio sensor at the patient location, and speech data is transmitted to a monitoring location. The audio sensor and other components at the patient location may be incorporated into, or associated with, a cell phone, computing system, or stand-alone microprocessor-based device, for example. Patient speech is processed at the patient location and/or monitoring location to identify speech parameters and/or patterns that indicate whether the patient has complied with the prescribed treatment regimen. Patient identity may be determined through biometric identification or other authentication techniques. The system may provide a report to an interested party, for example a medical care provider, based on whether (and/or the extent to which) the patient has complied with the prescribed treatment regimen.

Abstract: Methods and systems for monitoring compliance of a patient with a prescribed treatment regimen are described. Patient activity is detected unobtrusively with an activity sensor at the patient location, and activity data is transmitted to a monitoring location. Patient speech detected during use of a communication system such as a mobile telephone by the patient may also be used as an activity signal. Patient activity and/or speech is processed at the patient location or monitoring location to identify activity parameters or patterns that indicate whether the patient has complied with the prescribed treatment regimen. The activity sensor and other components at the patient location may be incorporated into, or associated with, a cell phone, computing system, game system, or vehicle system, for example. The system may provide a report to an interested party, for example a medical care provider or insurance company, regarding patient compliance with the prescribed treatment regimen.

Abstract: Described here are devices and methods that may facilitate treatment of a calcified heart valve with shock waves. A shock wave valvuloplasty device may be advanced through a patient's vasculature and self-align with cusps of a calcified aortic valve. Alignment may be facilitated by a central anchor and/or U-shaped distal bends of positioning wires. An elongated carrier may be slidably disposed over a portion of the positioning wire and carry one or more electrode assemblies that may generate shock waves. An inflatable balloon may sealably enclose the electrode assembles, and shock waves may propagate through the liquid-filled balloon and transfer energy to adjacent calcified valve cusps. The shock wave valvuloplasty device may comprise one or more features to direct shock waves to specific areas of calcified tissue. Some variations also comprise a central anchor configured to be positioned below the valve leaflets.

Abstract: Methods and systems for monitoring compliance of a patient with a prescribed treatment regimen are described. Compliance is determined based upon analysis of the patient's speech detected during use of a communication system such as a mobile telephone by the patient. Methods and systems as described herein can be used for monitoring patient compliance with a treatment for a brain-related disorder, for example. Identity of the patient as user of the communication system is determined through the use of e.g., biometric or authentication techniques. Speech data indicative of whether the patient has complied with the prescribed treatment regimen is transmitted from a circuitry-based system at the patient location to a monitoring location, where it may be reviewed by a medical caregiver or other party, for example. Patient speech may be analyzed at the patient location and/or subjected to analysis at the monitoring location.